Aurora Imaging Performs MRI Breast Biopsy
NORTH ANDOVER, Mass., Oct. 1 -- Aurora Imaging Technology Inc., developer of the first FDA-cleared magnetic resonance imaging system designed for breast examination, announced it has performed a biopsy procedure using its MRI-guided interventional system. Physicians at the Faulkner Hospital were able to identify a suspicious lesion that was undetected on mammography or ultrasound and performed an MRI-guided core biopsy that showed the lesion to be malignant.
The MRI-guided interventional system is designed to biopsy tissue for pathological study that is difficult to locate with ultrasound or traditional methods.
According to Elsie Levin, M.D., associate director of the Faulkner-Sagoff Breast Imaging and Diagnostic Centre, "Breast MRI is able to detect small lesions not detectable by ultrasound or mammography. In many instances, with the MR images, we are able to go back and find the lesion with ultrasound and perform the biopsy."
For more information, visit: www.auroramri.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024